Heart transplantation is the treatment of choice for patients with end-stage heart
failure [
[1]
,
[2]
]. Evaluation of outcome trends is imperative to identifying areas of improvement
and making goal-directed policies.Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol. 2013; 62: e147-e239
- The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth Adult Heart Transplantation Report-2018.Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant. 2018; (PMID)30293612
- Policy 6.5.C..2006 (http://optn.Transplant.Hrsa.Gov/policiesandbylaws2/policies/pdfs/policy_9.Pdf/)
- The new United States heart allocation policy: progress through collaborative revision.J Heart Lung Transplant. 2017; 36: 595-596
- Practice Changes at U.S. Transplant Centers After the New Adult Heart Allocation Policy.J Am Coll Cardiol. 2020; 75: 2906-2916
- The 4 Dimensions of Heart Allocation in an Increasingly Complex Universe.J Am Coll Cardiol. 2020; 75: 2917-2920
Article info
Publication history
Published online: January 22, 2021
Accepted:
January 2,
2021
Received in revised form:
December 29,
2020
Received:
December 9,
2020
Identification
Copyright
© 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
